ClinVar Miner

Submissions for variant NM_007279.3(U2AF2):c.530G>A (p.Gly177Glu)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center RCV004785100 SCV005397583 uncertain significance Developmental delay, dysmorphic facies, and brain anomalies 2024-02-06 criteria provided, single submitter clinical testing This sequence variant is a single nucleotide substitution (G>A) at position 530 of the coding sequence of the U2AF2 gene that results in a glycine to glutamic acid amino acid change at residue 177 of the U2 small nuclear RNA auxiliary factor 2 protein. This residue falls in the eukaryotic RNA recognition motif of the protein (UniProt). This variant is absent from ClinVar and publications. This variant is present in 1/628256 alleles (0.0002%) in the gnomAD v4.0.0 population database. Bioinformatic tools are inconclusive if this variant is likely to be damaging or tolerated, and the Gly177 residue at this position is highly conserved across the vertebrate species examined. Studies examining the functional consequence of this variant have not been performed, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PM2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.